deltatrials
Completed PHASE2 INTERVENTIONAL 2-arm NCT04552990

Use of Jet-injection in Photodynamic Therapy for Basal Cell Carcinoma

Jet-Injection Assisted Photodynamic Therapy for Basal Cell Carcinoma

Sponsor: Memorial Sloan Kettering Cancer Center

Conditions BCC BCC - Basal Cell Carcinoma Basal Cell Cancer Basal Cell Carcinoma Nodular Basal Cell Carcinoma Superficial Basal Cell Carcinoma
Interventions Illumination Incubation Jet injection of ALA Surgical excision
Updated 12 times since 2020 Last updated: Apr 17, 2025 Started: Sep 9, 2020 Primary completion: Apr 4, 2025 Completion: Apr 4, 2025
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on BCC and BCC - Basal Cell Carcinoma, this trial is completed. The trial is conducted by Memorial Sloan Kettering Cancer Center and has accumulated 12 data snapshots since 2020. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

~Oct 2020 – ~Dec 2020 · 2 months · monthly snapshotRecruiting~Dec 2020 – ~Jan 2021 · 31 days · monthly snapshotRecruiting~Jan 2021 – ~May 2021 · 4 months · monthly snapshotRecruiting~May 2021 – ~Mar 2022 · 10 months · monthly snapshotRecruiting~Mar 2022 – ~Mar 2023 · 12 months · monthly snapshotRecruiting~Mar 2023 – ~Jun 2023 · 3 months · monthly snapshotRecruiting~Jun 2023 – ~Jun 2024 · 12 months · monthly snapshotActive Not Recruiting~Jun 2024 – ~Jul 2024 · 30 days · monthly snapshotActive Not Recruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotActive Not Recruiting~Sep 2024 – ~Nov 2024 · 2 months · monthly snapshotActive Not Recruiting~Nov 2024 – ~May 2025 · 6 months · monthly snapshotActive Not Recruiting~May 2025 – present · 16 months · monthly snapshotCompleted

Change History

12 versions recorded

  1. May 2025 — Present [monthly]

    Completed PHASE2

    Status: Active Not Recruiting → Completed

  2. Nov 2024 — May 2025 [monthly]

    Active Not Recruiting PHASE2

  3. Sep 2024 — Nov 2024 [monthly]

    Active Not Recruiting PHASE2

  4. Jul 2024 — Sep 2024 [monthly]

    Active Not Recruiting PHASE2

  5. Jun 2024 — Jul 2024 [monthly]

    Active Not Recruiting PHASE2

▶ Show 7 earlier versions

  1. Jun 2023 — Jun 2024 [monthly]

    Active Not Recruiting PHASE2

    Status: Recruiting → Active Not Recruiting

  2. Mar 2023 — Jun 2023 [monthly]

    Recruiting PHASE2

  3. Mar 2022 — Mar 2023 [monthly]

    Recruiting PHASE2

  4. May 2021 — Mar 2022 [monthly]

    Recruiting PHASE2

  5. Jan 2021 — May 2021 [monthly]

    Recruiting PHASE2

  6. Dec 2020 — Jan 2021 [monthly]

    Recruiting PHASE2

  7. Oct 2020 — Dec 2020 [monthly]

    Recruiting PHASE2

    First recorded

Sep 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Memorial Sloan Kettering Cancer Center
Data source: Memorial Sloan Kettering Cancer Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations